Akums Drugs & Pharmaceuticals Q2 Results 2025 Highlights: Net Profit Falls 37.46% & Revenue Down 1.51% YoY

Click and Sign Up to Get Live Updates on Q2 Results

Updated: 24 Nov 2025 • 12:55 pm

Posted by:

Akums Drugs & Pharmaceuticals Q2 Results 2025 Highlights: Net Profit Falls 37.46% & Revenue Down 1.51% YoY

Akums Drugs and Pharmaceuticals Q2 Results FY26: During Q2 FY26, Akums Drugs & Pharmaceuticals' profit decreased 37.46% YoY, while revenue decreased by 1.51% YoY. The company posted robust numbers, with Q2 PAT at ₹40.78 crores and revenue at ₹1,017.53 crores. Akums Drugs & Pharmaceuticals announced its Q2 results on 14th November 2025.

Table of Contents

Akums Drugs and Pharmaceuticals Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

Particulars	Quarter Ended
Particulars	30-09-2025	30-09-2024
Revenue from Operations	₹1,017.53	₹1,033.09
Profit Before Tax (PBT)	₹126.84	₹134.66
Profit After Tax (PAT)	₹40.76	₹65.21

(Figures in crores)

Akums Drugs & Pharmaceuticals Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

Particulars	Quarter Ended
Particulars	30-09-2025	30-09-2024
Revenue from Operations	₹302.32	₹328.35
Profit Before Tax (PBT)	₹43.97	₹75.19
Profit After Tax (PAT)	₹23.46	₹50.37

(Figures in crores)

Akums Drugs and Pharmaceuticals Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

Akums Drugs & Pharmaceuticals clocked Q2 FY26 consolidated revenue of ₹1,017.53 crores vs ₹1,033.09 crores.
On the profit front, Akums Drugs & Pharmaceuticals earned a consolidated PAT of ₹40.76 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹65.21 crore.
According to the consolidated figures, Akums Drugs & Pharmaceuticals' quarterly PAT decreased by 37.46% YoY, while revenue decreased by 1.51%.
Akums Drugs & Pharmaceuticals clocked Q2 FY26 standalone revenue of ₹302.32 crores vs ₹328.35 crores.
On the profit front, Akums Drugs & Pharmaceuticals earned a standalone PAT of ₹23.46 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹50.37 crore.
According to the standalone figures, Akums Drugs & Pharmaceuticals' quarterly PAT decreased by 53.42% YoY, while revenue decreased by 5.80%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Akums Drugs and Pharmaceuticals Share Price Performance

On the opening bell on 24th November 2025, Akums Drugs & Pharmaceuticals shares opened at ₹421.50 per share. However, the initial gains have since eroded, and Akums Drugs & Pharmaceuticals shares are currently trading at ₹415.50 per share, lower than the opening price.

Considering the long-term performance, Akums Drugs & Pharmaceuticals shares have yielded returns of approximately -28.54% over the past 6 months and -38.14% over the past 1 year. Over the maximum timeframe, Akums Drugs & Pharmaceuticals shares delivered a return of -48.29% to investors.

What Analysts Expect Post Q2 Results?

Following Akums Drugs & Pharmaceuticals' robust Q2 results, analysts expect its share price to rise. According to analysts, Akums Drugs & Pharmaceuticals' share price is expected to reach ₹464.50 per share in the coming year; however, in a downturn, it could fall to ₹398.40 per share. However, one must ignore stock market volatility and invest in Akums Drugs & Pharmaceuticals' shares after thorough research.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.